Suzanne Louise Topalian

机构：Bloomberg (United States), Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center · ORCID：0000-0002-0821-8587

发表论文 356 篇 · 总被引 98934 次 · h-index 102

代表论文

• Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy (2023 · Cancer Cell · 被引 312)
• Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial (2024 · The Lancet Oncology · 被引 68)
• Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers (2024 · Journal of Clinical Oncology · 被引 57)
• Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma (2024 · Cell Reports Medicine · 被引 26)
• Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study (2025 · Journal of Clinical Oncology · 被引 22)
• Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effort (2025 · Annals of Oncology · 被引 18)